Found: 49
Select item for more details and to access through your institution.
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion.
- Published in:
- Movement Disorders Clinical Practice, 2024, v. 11, n. 9, p. 1095, doi. 10.1002/mdc3.14138
- By:
- Publication type:
- Article
Optimizing Treatment of Parkinson's Disease.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020245
- By:
- Publication type:
- Article
Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 8, p. 720, doi. 10.3390/jpm11080720
- By:
- Publication type:
- Article
Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 254, doi. 10.3390/jpm11040254
- By:
- Publication type:
- Article
Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden.
- Published in:
- Applied Health Economics & Health Policy, 2009, v. 7, n. 3, p. 167, doi. 10.1007/BF03256150
- By:
- Publication type:
- Article
Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings.
- Published in:
- Sensors (14248220), 2017, v. 17, n. 10, p. 2341, doi. 10.3390/s17102341
- By:
- Publication type:
- Article
Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease.
- Published in:
- Sensors (14248220), 2015, v. 15, n. 9, p. 23727, doi. 10.3390/s150923727
- By:
- Publication type:
- Article
Automatic and Objective Assessment of Alternating Tapping Performance in Parkinson's Disease.
- Published in:
- Sensors (14248220), 2013, v. 13, n. 12, p. 16965, doi. 10.3390/s131216965
- By:
- Publication type:
- Article
Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 2, p. 424, doi. 10.1002/ana.22257
- By:
- Publication type:
- Article
Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 2, p. 481, doi. 10.1002/mds.28391
- By:
- Publication type:
- Article
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 10, p. 1299, doi. 10.1007/s00228-018-2497-2
- By:
- Publication type:
- Article
Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 563, doi. 10.1007/s00228-017-2196-4
- By:
- Publication type:
- Article
Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases.
- Published in:
- Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00472-x
- By:
- Publication type:
- Article
Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
- Published in:
- Fluids & Barriers of the CNS, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12987-022-00306-2
- By:
- Publication type:
- Article
Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
- Published in:
- Fluids & Barriers of the CNS, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12987-022-00306-2
- By:
- Publication type:
- Article
Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism.
- Published in:
- Fluids & Barriers of the CNS, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12987-021-00270-3
- By:
- Publication type:
- Article
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients.
- Published in:
- AAPS Journal, 2013, v. 15, n. 2, p. 316, doi. 10.1208/s12248-012-9439-1
- By:
- Publication type:
- Article
Close relationships in Parkinson´s disease patients with device‐aided therapy.
- Published in:
- Brain & Behavior, 2021, v. 11, n. 6, p. 1, doi. 10.1002/brb3.2102
- By:
- Publication type:
- Article
A survey of lifestyle factors in dystonia.
- Published in:
- Brain & Behavior, 2020, v. 10, n. 12, p. 1, doi. 10.1002/brb3.1871
- By:
- Publication type:
- Article
Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".
- Published in:
- 2016
- By:
- Publication type:
- letter
Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Continuous Drug Delivery in Parkinson's Disease.
- Published in:
- CNS Drugs, 2014, v. 28, n. 1, p. 19, doi. 10.1007/s40263-013-0127-1
- By:
- Publication type:
- Article
Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington’s disease subjects.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-40186-5
- By:
- Publication type:
- Article
Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221108018
- By:
- Publication type:
- Article
Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-world experience and practical guidance.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, v. 15, p. 1, doi. 10.1177/17562864221108018
- By:
- Publication type:
- Article
Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 3, p. 171, doi. 10.1177/1756285616681280
- By:
- Publication type:
- Article
Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System.
- Published in:
- JMIR Formative Research, 2022, v. 6, n. 6, p. 1, doi. 10.2196/31485
- By:
- Publication type:
- Article
Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus.
- Published in:
- Journal of Neuroimaging, 2022, v. 32, n. 1, p. 90, doi. 10.1111/jon.12932
- By:
- Publication type:
- Article
Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia—a phase 1b trial.
- Published in:
- NPJ Parkinson's Disease, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41531-018-0071-3
- By:
- Publication type:
- Article
Validation of a home environment test battery for supporting assessments in advanced Parkinson's disease.
- Published in:
- Neurological Sciences, 2012, v. 33, n. 4, p. 831, doi. 10.1007/s10072-011-0844-5
- By:
- Publication type:
- Article
Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases.
- Published in:
- BMC Palliative Care, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12904-021-00848-6
- By:
- Publication type:
- Article
Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 3, p. 1065, doi. 10.1093/brain/awac124
- By:
- Publication type:
- Article
Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment.
- Published in:
- BMC Medical Ethics, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12910-023-00966-1
- By:
- Publication type:
- Article
Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment.
- Published in:
- BMC Medical Ethics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12910-022-00878-6
- By:
- Publication type:
- Article
Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 3, p. 651, doi. 10.1007/s00415-019-09183-6
- By:
- Publication type:
- Article
Motor fluctuations and <i>Helicobacter pylori</i> in Parkinson’s disease.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 12, p. 2974, doi. 10.1007/s00415-013-7089-6
- By:
- Publication type:
- Article
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 11, p. 2701, doi. 10.1007/s00415-012-6798-6
- By:
- Publication type:
- Article
The Impact of COVID-19 on Parkinson's Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions.
- Published in:
- Acta Neurologica Scandinavica, 2023, p. 1, doi. 10.1155/2023/8025566
- By:
- Publication type:
- Article
The effect of continuous levodopa treatment during the afternoon hours.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 1, p. 70, doi. 10.1111/ane.13020
- By:
- Publication type:
- Article
Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry.
- Published in:
- CNS Neuroscience & Therapeutics, 2018, v. 24, n. 5, p. 439, doi. 10.1111/cns.12807
- By:
- Publication type:
- Article
Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease.
- Published in:
- Movement Disorders, 2004, v. 19, n. 4, p. 446, doi. 10.1002/mds.10690
- By:
- Publication type:
- Article
Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [11C]PE2I PET-MR brain imaging.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. 1, doi. 10.1186/s40658-020-00347-2
- By:
- Publication type:
- Article
Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging—comparison to head atlas and <sup>68</sup>Ge-transmission-based attenuation correction.
- Published in:
- EJNMMI Physics, 2018, v. 5, n. 1, p. 1, doi. 10.1186/s40658-018-0220-0
- By:
- Publication type:
- Article
Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Use of <sup>11</sup>C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 234, doi. 10.2967/jnumed.114.148619
- By:
- Publication type:
- Article